Cancer Immunology and Immunotherapy

Content:
The course covers all the main aspect of cancer immunology and immunotherapy, from the bench to the bedside. The focus of the course shifts between day 1-2, where basic and translational research are the main topics, to day 3-4 where the application of this knowledge in the clinic is presented. Day 1-2, are focused on the main aspects of the generation of immune response to cancer, avoidance of immune destruction, immune targets on cancer cells, how to evaluate immune response to cancer, how to apply this knowledge to develop novel treatments. Day 3-4 are mainly dedicated to the application of cancer immunotherapy in the clinical arena to cover both clinical research and real-wold application of cancer immunotherapies in modern health systems, from a clinician and a patient's perspective. Day 4 will include specific sessions to facilitate knowledge sharing between the students and the main course supervisors, and an exercise about designing a cancer immunology or immunotherapy research program.

Day 5 will be dedicated to the international expert talks, including a clinical-translational workshop, based on topics discussed in day 1-4.

Participants:
The course is relevant for PhD students who work on cancer or immunology related PhD projects, and aim to broaden their knowledge on basic, translational and clinical aspects of cancer immunology research. As such, PhD students engaged in basic, applied, and clinical cancer research projects are all welcome.

Form:
Lectures, group works and exercises

Course director:
Marco Donia, MD, PhD, junior group leader, CCIT-DK, Herlev Hospital.